companydata.dkCONTERA PHARMA A/S: Financial statements 2016
CVR: 33062214
CONTERA PHARMA A/S (CVR 33062214) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 3,107,817 and a net result of DKK 866,364 compared with DKK -1,083,182 the year before. That is an increase of 597.9% compared with the year before. Equity amounted to DKK 1,466,894. The solvency ratio was 89%.
- Gross Profit
- 3,107,817 kr.
- Profit/Loss
- 866,364 kr.
- Equity
- 1,466,894 kr.
- Total Assets
- 1,648,349 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 3.1 mio. | 866 t. | 1.5 mio. | - |
| 2015 | - | 445 t. | -1.1 mio. | 601 t. | - |
| 2014 | - | -126 t. | -3.2 mio. | 1.7 mio. | - |
| 2013 | - | -3.4 mio. | -4.7 mio. | 1.7 mio. | - |
| 2012 | - | -3.7 mio. | -4.2 mio. | 6.4 mio. | - |
How creditworthy is CONTERA PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
CONTERA PHARMA A/S has published its annual report for 2015. Gross profit came to DKK 445,321, and the net result was DKK -1,083,182.
About CONTERA PHARMA A/S
CONTERA PHARMA A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CONTERA PHARMA ApS and CONCIT PHARMA ApS. The management consists of Thomas Nikolaj Sager. The company is owned by Bukwang Pharmaceutical Co., Ltd. The company has 1 employee. In 2025, the company reported a gross profit of DKK 20,632,306 and a net result of DKK -4,783,781 compared with DKK -69,213,744 the year before. Equity amounted to DKK 79,471,802.